Cyclooxygenase-2 inhibition increases lipopolysaccharide-induced atherosclerosis in mice
Open Access
- 22 October 2008
- journal article
- research article
- Published by Oxford University Press (OUP) in Cardiovascular Research
- Vol. 81 (2), 400-407
- https://doi.org/10.1093/cvr/cvn286
Abstract
The risk of adverse cardiovascular events in humans is increased with chronic use of cyclooxygenase-2 (COX-2) inhibitors. However, the role of COX-2 in animal models of cardiovascular disease has been controversial. In humans and animal models, cardiovascular disease is increased by bacterial infection of the supporting tissue of the teeth, a condition known as periodontal disease. Periodontal disease may result in chronic exposure to pro-inflammatory mediators, such as bacterial lipopolysaccharide (LPS), thereby producing a systemic inflammatory response. The current study examined the role of COX-2 in atherosclerosis induced by LPS derived from the periodontal disease pathogen Porphyromonas gingivalis (P. gingivalis). Porphyromonas gingivalis LPS was administered by chronic infusion for 28 days and atherosclerosis development was examined in the aortic root of ApoE (apolipoprotein E)-deficient mice. The extent of atherosclerosis was compared between mice receiving control diet or diet containing the COX-2 inhibitor celecoxib. The role of COX-2 in P. gingivalis LPS-induced inflammatory cell activation was examined in peritoneal macrophages. Porphyromonas gingivalis LPS infusion significantly increased atherosclerosis development. In mice infused with P. gingivalis LPS, administration of the COX-2 inhibitor celecoxib further increased the extent of atherosclerotic lesion area. In peritoneal macrophages, P. gingivalis LPS increased the expression of COX-2 mRNA (messenger ribonucleic acid) and the production of prostaglandin (PG) E2 (PGE2), the latter of which was inhibited by celecoxib. Porphyromonas gingivalis LPS-induced expression of tumour necrosis factor alpha (TNFα) was enhanced by inactivation of COX-2 and was attenuated by treatment with PGE2. The inhibition of COX-2-derived PGE2 may enhance P. gingivalis LPS-induced atherosclerosis by increasing macrophage production of TNFα.This publication has 35 references indexed in Scilit:
- Selective Cyclooxygenase-2 Inhibition With Celecoxib Decreases Angiotensin II-Induced Abdominal Aortic Aneurysm Formation in MiceArteriosclerosis, Thrombosis, and Vascular Biology, 2006
- Cyclooxygenase-2 promotes early atherosclerotic lesion formation in ApoE-deficient and C57BL/6 miceJournal of Molecular and Cellular Cardiology, 2005
- Early Growth Response Factor-1 Mediates Prostaglandin E2-dependent Transcriptional Suppression of Cytokine-induced Tumor Necrosis Factor-α Gene Expression in Human Macrophages and Rheumatoid Arthritis-affected Synovial FibroblastsOnline Journal of Public Health Informatics, 2005
- Human Apolipoprotein A-IV Reduces Secretion of Proinflammatory Cytokines and Atherosclerotic Effects of a Chronic Infection Mimicked by LipopolysaccharideArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Porphyromonas gingivalisInfection Accelerates the Progression of Atherosclerosis in a Heterozygous Apolipoprotein E–Deficient Murine ModelCirculation, 2002
- Signaling by Toll-Like Receptor 2 and 4 Agonists Results in Differential Gene Expression in Murine MacrophagesInfection and Immunity, 2001
- Prostaglandin E2 Receptors, EP2 and EP4, Differentially Modulate TNF-α and IL-6 Production Induced by Lipopolysaccharide in Mouse Peritoneal NeutrophilsBiochemical and Biophysical Research Communications, 2000
- Cyclooxygenase-2-Dependent Prostaglandin Production by Peripheral Blood Monocytes Stimulated With Lipopolysaccharides Isolated From Periodontopathogenic BacteriaThe Journal of Periodontology, 2000
- Clinical Pharmacokinetics and Pharmacodynamics of CelecoxibClinical Pharmacokinetics, 2000
- Association between dental health and acute myocardial infarction.BMJ, 1989